SNSE (SNSE)
Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
—
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
Live quote temporarily unavailable — press releases and news are still shown below.
No company overview is available for SNSE yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
SNSE has not issued a press release in this window.
SEC filings
All filings →SNSE has not filed an SEC document in this window.
Insider trades
All insider trades →SNSE has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-03-31 · prior 2024-12-31
Ikarian Capital, LLC$177,285
449,963 sh-30.8%
VANGUARD GROUP INC$230,717
585,576 sh-1.5%
108,658 sh-37.1%
Catalio Capital Management, LP$115,983
294,374 sh0.0%
UBS Group AG$16,761
42,541 sh+2126950.0%
150,709 sh+1.2%
16,514 sh● NEW
RENAISSANCE TECHNOLOGIES LLC$69,856
177,300 sh+13.1%
People at SNSE
All people →Quarterly financials
Full financials →Revenue trend
03/25
—
NI -$6.9M
06/25
—
NI -$4.9M
09/25
—
NI -$4.6M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-3.62
Prior: $-3.91
Revenue sparkline